K. Toga

Characterization of whole blood aggregation with a new type of aggregometer by a screen filtration pressure method.

T. Sudo, Y. Kimura, T. Ogawa, 2001, Thrombosis research.

Expression of murine dihydrofolate reductase complementary DNA in oocytes of Xenopus laevis.

S. Ikegami, K. Toga, N. Itoh, 1991, The International journal of biochemistry.

Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity.

H. Hidaka, S. Tochizawa, T. Sudo, 2000, Biochemical pharmacology.

A new peptide vaccine OCV-501: in vitro pharmacology and phase 1 study in patients with acute myeloid leukemia

Y. Heike, S. Miyawaki, Yukio Kobayashi, 2017, Cancer Immunology, Immunotherapy.

Genetic strain differences in platelet aggregation and thrombus formation of laboratory rats

H. Hayashi, Hideki Ito, Yoshihisa Yamada, 2007, Thrombosis and Haemostasis.

2(1H)-quinolinone derivatives as novel anti-arteriostenotic agents showing anti-thrombotic and anti-hyperplastic activities.

H. Hidaka, M. Okada, S. Tochizawa, 1998, Bioorganic & medicinal chemistry letters.

Suppression of arterial intimal hyperplasia by cilostamide, a cyclic nucleotide phosphodiesterase 3 inhibitor, in a rat balloon double‐injury model

Y. Yoshida, S. Tochizawa, T. Sudo, 2000, British journal of pharmacology.